The antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT): The largest hypertension study ever undertaken: Baseline characteristics

被引:0
|
作者
Grimm, RH
Davis, BR
Ford, C
Alderman, MH
Black, HR
Cushman, WC
Dequattro, V
Papademetriou, V
机构
[1] SHAPIRO CTR EVIDENCE BASED MED,MINNEAPOLIS,MN
[2] COORDINATING CTR CLIN TRIALS,HOUSTON,TX
[3] ALBERT EINSTEIN COLL MED,BRONX,NY 10467
[4] RUSH MED COLL,CHICAGO,IL 60612
[5] UNIV TENNESSEE,MEMPHIS,TN
[6] UNIV SO CALIF,LOS ANGELES,CA
[7] MINNEAPOLIS MED RES FDN INC,WASHINGTON,DC
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1542 / 1542
页数:1
相关论文
共 50 条
  • [41] The relation of hypokalemia at 1 year to morbidity and mortality: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) experience
    Alderman, M.
    Piller, L.
    Ford, C.
    Davis, B.
    Einhorn, P.
    Cushman, W.
    Calhoun, D.
    Eckfeldt, J.
    EUROPEAN HEART JOURNAL, 2005, 26 : 671 - 671
  • [42] Legacy Effects of Baseline Blood Pressure 'Treatment Naivety' on All-cause and Cardiovascular Mortality in the Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Ho, Chau
    Bresliln, Monique
    Chowdhury, Enayet
    Doust, Jenny
    Reid, Christopher M.
    Davis, Barry R.
    Simpson, Lara M.
    Nelson, Mark R.
    CIRCULATION, 2019, 140
  • [43] Relationship of 1 year hypokalemia incidence to clinical outcomes in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    Alderman, Michael
    Calhoun, David
    Cushman, William
    Davis, Barry
    Eckfeldt, John
    Einhorn, Paula
    Ford, Charles
    Franklin, Stanley
    Furberg, Curt
    Ong, Stephen
    Oparil, Suzanne
    Papademetriou, Vasilios
    Piller, Linda
    Probstfield, Jeffrey
    CIRCULATION, 2006, 114 (18) : 576 - 576
  • [44] Heart failure results in the antihypertensive and lipid-lowering treatment to prevent heart attack trial
    Davis, B
    EUROPEAN HEART JOURNAL, 2004, 25 : 122 - 122
  • [45] Stroke results in the antihypertensive and lipid-lowering treatment to prevent heart attack trial
    Oparil, S
    Davis, BR
    Nwachuku, C
    Pressel, S
    deLeon, B
    STROKE, 2004, 35 (01) : 235 - 235
  • [46] Antihypertensive treatments in obese patients: the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial experience
    Jordan, Jens
    Engeli, Stefan
    JOURNAL OF HYPERTENSION, 2014, 32 (07) : 1402 - 1404
  • [47] Long-Term Follow-Up of Participants With Heart Failure in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Piller, Linda B.
    Baraniuk, Sarah
    Simpson, Lara M.
    Cushman, William C.
    Massie, Barry M.
    Einhorn, Paula T.
    Oparil, Suzanne
    Ford, Charles E.
    Graumlich, James F.
    Dart, Richard A.
    Parish, David C.
    Retta, Tamrat M.
    Cuyjet, Aloysius B.
    Jafri, Syed Z.
    Furberg, Curt D.
    Saklayen, Mohammad G.
    Thadani, Udho
    Probstfield, Jeffrey L.
    Davis, Barry R.
    CIRCULATION, 2011, 124 (17) : 1811 - U88
  • [48] Response to letter regarding article, "Role of diuretics in the prevention of heart failure: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)"
    Davis, Barry R.
    Piller, Linda B.
    Dunn, Kay
    CIRCULATION, 2007, 115 (02) : E19 - E19
  • [49] Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome - Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Wright, Jackson T.
    Harris-Haywood, Sonja
    Pressel, Sara
    Barzilay, Joshua
    Bairnbridge, Charles
    Bareis, Charles J.
    Basile, Jan N.
    Black, Henry R.
    Dart, Richard
    Gupta, Alok K.
    Hamilton, Bruce P.
    Einhorn, Paula T.
    Haywood, L. Julian
    Jafri, Syed Z. A.
    Louis, Gail T.
    Whelton, Paul K.
    Scott, Cranford L.
    Sinnnons, Debra L.
    Stanford, Carol
    Davis, Barry R.
    ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (02) : 207 - 217